NASDAQ:ELOS - Syneron Medical Stock Price, Price Target & More

$11.00 0.00 (0.00 %)
(As of 04/26/2018 01:35 AM ET)
Previous Close$11.00
Today's Range$11.00 - $11.00
52-Week Range$6.18 - $11.43
Volume3,905 shs
Average Volume562,777 shs
Market Capitalization$387.56 million
P/E RatioN/A
Dividend YieldN/A
Beta1.25

About Syneron Medical (NASDAQ:ELOS)

Syneron Medical logoSyneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company's aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments. The Company's products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, tattoo removal, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and laser-assisted lipolysis.

Receive ELOS News and Ratings via Email

Sign-up to receive the latest news and ratings for ELOS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:ELOS
CUSIPN/A
Phone+972-7-32442200

Debt

Debt-to-Equity RatioN/A
Current Ratio2.68%
Quick Ratio1.84%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-1.09%
Return on Equity-1.74%
Return on Assets-1.30%

Miscellaneous

Employees817
Outstanding Shares35,230,000

How to Become a New Pot Stock Millionaire

Syneron Medical (NASDAQ:ELOS) Frequently Asked Questions

What is Syneron Medical's stock symbol?

Syneron Medical trades on the NASDAQ under the ticker symbol "ELOS."

How were Syneron Medical's earnings last quarter?

Syneron Medical Ltd. (NASDAQ:ELOS) posted its quarterly earnings data on Thursday, August, 4th. The medical equipment provider reported $0.09 EPS for the quarter, topping the consensus estimate of $0.06 by $0.03. The medical equipment provider had revenue of $75 million for the quarter, compared to analyst estimates of $75.72 million. Syneron Medical had a negative net margin of 1.09% and a negative return on equity of 1.74%. Syneron Medical's quarterly revenue was up 2.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.07 earnings per share. View Syneron Medical's Earnings History.

What price target have analysts set for ELOS?

1 brokerages have issued 12-month target prices for Syneron Medical's shares. Their predictions range from $11.00 to $11.00. On average, they expect Syneron Medical's share price to reach $11.00 in the next twelve months. View Analyst Ratings for Syneron Medical.

Who are Syneron Medical's key executives?

Syneron Medical's management team includes the folowing people:
  • Shimon Eckhouse Ph.D., Chairman of the Board
  • Amit Meridor, Chief Executive Officer
  • , Bio & Compensation - 
  • Hugo Goldman, Chief Financial Officer
  • , Bio & Compensation - 
  • Erik Dowell, Vice President-North America
  • William Griffing, Chief Executive Officer - Syneron Candela North America
  • Shlomo Alkalay, Chief Operating Officer
  • Lisa A. Soderquist, Chief Human Resource Officer
  • , Bio & Compensation - 
  • Robert Ruck, Executive Vice President, Asia Pacific
  • Robert Fielitz, Vice President and Managing Director of Europe, Middle East and Africa
  • Sarit Soccary Ben-Yochanan, Vice President - Business Development & Strategy

Has Syneron Medical been receiving favorable news coverage?

News articles about ELOS stock have been trending somewhat positive recently, Accern Sentiment reports. Accern identifies negative and positive press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Syneron Medical earned a coverage optimism score of 0.09 on Accern's scale. They also assigned media stories about the medical equipment provider an impact score of 44.63 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

How do I buy shares of Syneron Medical?

Shares of ELOS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Syneron Medical's stock price today?

One share of ELOS stock can currently be purchased for approximately $11.00.

How big of a company is Syneron Medical?

Syneron Medical has a market capitalization of $387.56 million. Syneron Medical employs 817 workers across the globe.

How can I contact Syneron Medical?

Syneron Medical's mailing address is Tavor Building 4 P.O. Box 550, YOKNEAM, 2069200, Israel. The medical equipment provider can be reached via phone at +972-7-32442200.


MarketBeat Community Rating for Syneron Medical (ELOS)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  192 (Vote Outperform)
Underperform Votes:  124 (Vote Underperform)
Total Votes:  316
MarketBeat's community ratings are surveys of what our community members think about Syneron Medical and other stocks. Vote "Outperform" if you believe ELOS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ELOS will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Syneron Medical (NASDAQ:ELOS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Syneron Medical in the last 12 months. Their average twelve-month price target is $11.00, suggesting that the stock has a possible downside of 0.00%. The high price target for ELOS is $11.00 and the low price target for ELOS is $11.00. There are currently 1 hold rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.002.002.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $11.00$11.00$11.00$11.00
Price Target Upside: 0.00% downside1.38% upside1.38% upside1.38% upside

Syneron Medical (NASDAQ:ELOS) Consensus Price Target History

Price Target History for Syneron Medical (NASDAQ:ELOS)

Syneron Medical (NASDAQ:ELOS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/12/2017Maxim GroupDowngradeBuy -> Hold$12.00 -> $11.00MediumView Rating Details
10/24/2016Brean CapitalReiterated RatingBuyN/AView Rating Details
8/5/2016Leerink SwannDowngradeOutperform -> Market Perform$9.40 -> $7.80N/AView Rating Details
(Data available from 4/26/2016 forward)

Earnings

Syneron Medical (NASDAQ:ELOS) Earnings History and Estimates Chart

Earnings by Quarter for Syneron Medical (NASDAQ:ELOS)

Syneron Medical (NASDAQ ELOS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/17/2017Q1 2017($0.14)$69.60 million$66.88 millionViewN/AView Earnings Details
2/15/2017Q416$0.03($0.03)$82.02 million$82.90 millionViewListenView Earnings Details
11/9/2016Q316($0.02)$0.02$68.08 million$71.50 millionViewListenView Earnings Details
8/4/2016Q216$0.06$0.09$75.72 million$75.00 millionViewListenView Earnings Details
5/19/2016Q116$0.01$0.04$64.38 million$68.70 millionViewListenView Earnings Details
2/22/2016Q415$0.07$0.07$75.56 million$78.90 millionViewListenView Earnings Details
11/11/2015Q315$0.03$0.03$66.60 million$62.10 millionViewListenView Earnings Details
8/4/2015Q215$0.06$0.04$70.93 million$73.50 millionViewN/AView Earnings Details
5/13/2015Q115$0.01$0.02$62.08 million$63.40 millionViewListenView Earnings Details
2/18/2015Q414$0.06$0.09$71.42 million$74.10 millionViewN/AView Earnings Details
11/12/2014Q314$0.03$0.03$58.32 million$60.30 millionViewN/AView Earnings Details
8/6/2014Q214$0.07$0.07$63.52 million$64.60 millionViewListenView Earnings Details
5/14/2014Q114$0.04$0.04$55.50 million$56.80 millionViewN/AView Earnings Details
2/20/2014Q413$0.08$0.11$65.70 million$64.30 millionViewListenView Earnings Details
11/13/2013Q313$0.01$0.04$62.06 million$62.70 millionViewListenView Earnings Details
8/14/2013Q2 2013$0.09$0.02$70.93 million$68.80 millionViewN/AView Earnings Details
5/22/2013Q1 2013$0.02$0.02$61.19 million$61.20 millionViewN/AView Earnings Details
2/12/2013Q4 2012$0.09$0.11$70.60 million$72.80 millionViewN/AView Earnings Details
11/7/2012Q312$0.04$0.03$65.51 million$60.13 millionViewN/AView Earnings Details
8/15/2012$0.04$0.05ViewN/AView Earnings Details
5/9/2012Q1 2012($0.12)($0.01)ViewN/AView Earnings Details
2/9/2012$0.04$0.03ViewN/AView Earnings Details
11/10/2011($0.09)($0.03)ViewN/AView Earnings Details
8/11/2011($0.02)($0.01)ViewN/AView Earnings Details
5/19/2011($0.04)$0.01ViewN/AView Earnings Details
2/16/2011($0.04)$0.24ViewN/AView Earnings Details
11/11/2010Q3 2010($0.16)($0.07)ViewN/AView Earnings Details
8/12/2010Q2 2010($0.12)($0.13)ViewN/AView Earnings Details
5/13/2010Q1 2010($0.10)($0.17)ViewN/AView Earnings Details
2/11/2010Q4 2009($0.11)($0.16)ViewN/AView Earnings Details
11/9/2009Q3 2009($0.15)($0.20)ViewN/AView Earnings Details
8/13/2009Q2 2009($0.22)($0.20)ViewN/AView Earnings Details
5/14/2009Q1 2009($0.20)($0.30)ViewN/AView Earnings Details
2/12/2009Q4 2008$0.08($0.58)ViewN/AView Earnings Details
11/11/2008Q3 2008$0.12$0.08ViewN/AView Earnings Details
8/14/2008Q2 2008$0.34$0.32ViewN/AView Earnings Details
5/14/2008Q1 2008$0.30$0.30ViewN/AView Earnings Details
2/12/2008Q4 2007$0.34$0.37ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Syneron Medical (NASDAQ:ELOS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Syneron Medical (NASDAQ ELOS) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 69.17%
Insider Trading History for Syneron Medical (NASDAQ:ELOS)
Institutional Ownership by Quarter for Syneron Medical (NASDAQ:ELOS)

Syneron Medical (NASDAQ ELOS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Syneron Medical (NASDAQ ELOS) News Headlines

Source:
DateHeadline
C R Bard (BCR) & Syneron Medical (ELOS) Head-To-Head AnalysisC R Bard (BCR) & Syneron Medical (ELOS) Head-To-Head Analysis
www.americanbankingnews.com - March 21 at 11:05 AM
Head-To-Head Comparison: Orthofix International (OFIX) versus Syneron Medical (ELOS)Head-To-Head Comparison: Orthofix International (OFIX) versus Syneron Medical (ELOS)
www.americanbankingnews.com - December 30 at 7:12 PM
Sientra (SIEN) versus Syneron Medical (ELOS) Critical ReviewSientra (SIEN) versus Syneron Medical (ELOS) Critical Review
www.americanbankingnews.com - November 7 at 10:58 AM
Head to Head Contrast: Syneron Medical (ELOS) and Its CompetitorsHead to Head Contrast: Syneron Medical (ELOS) and Its Competitors
www.americanbankingnews.com - September 20 at 2:23 PM
Intersect ENT (XENT) versus Syneron Medical (ELOS) Head to Head ComparisonIntersect ENT (XENT) versus Syneron Medical (ELOS) Head to Head Comparison
www.americanbankingnews.com - September 19 at 2:30 PM
Comparing Syneron Medical (ELOS) & Align Technology (ALGN)Comparing Syneron Medical (ELOS) & Align Technology (ALGN)
www.americanbankingnews.com - July 27 at 9:10 AM
Syneron Candela Completes Previously Announced Transaction with Funds Advised by Apax Partners and Becomes a Private CompanySyneron Candela Completes Previously Announced Transaction with Funds Advised by Apax Partners and Becomes a Private Company
finance.yahoo.com - July 17 at 11:14 AM
Medtech Mergers Surge AgainMedtech Mergers Surge Again
seekingalpha.com - July 10 at 11:12 PM
ETFs with exposure to Syneron Medical Ltd. : July 10, 2017ETFs with exposure to Syneron Medical Ltd. : July 10, 2017
finance.yahoo.com - July 10 at 6:07 PM
Syneron Medical Ltd. breached its 50 day moving average in a Bearish Manner : ELOS-US : July 7, 2017Syneron Medical Ltd. breached its 50 day moving average in a Bearish Manner : ELOS-US : July 7, 2017
finance.yahoo.com - July 8 at 10:29 AM
Syneron Candela (ELOS) Announces Expiration of Go-Shop PeriodSyneron Candela (ELOS) Announces Expiration of Go-Shop Period
www.streetinsider.com - May 10 at 5:06 PM
Apax to buy Israeli aesthetic device firm Syneron for $397 mlnApax to buy Israeli aesthetic device firm Syneron for $397 mln
us.rd.yahoo.com - April 3 at 10:17 PM
Apax to buy Israeli aesthetic device firm Syneron for $397 millionApax to buy Israeli aesthetic device firm Syneron for $397 million
us.rd.yahoo.com - April 3 at 10:17 PM
Syneron Medical (ELOS) Jumps on Apax DealSyneron Medical (ELOS) Jumps on Apax Deal
www.baystreet.ca - April 3 at 5:16 PM
Syneron Medical Agrees To Be Bought By Apax Partners For $397 Mln - Quick FactsSyneron Medical Agrees To Be Bought By Apax Partners For $397 Mln - Quick Facts
www.nasdaq.com - April 3 at 5:16 PM
Syneron Medical Ltd. stock rises after nearly $400 mln acquisition of outstanding sharesSyneron Medical Ltd. stock rises after nearly $400 mln acquisition of outstanding shares
www.marketwatch.com - April 3 at 5:16 PM
Apax eyes IPO for investment house Psagot in Tel Aviv -sourceApax eyes IPO for investment house Psagot in Tel Aviv -source
uk.finance.yahoo.com - April 3 at 7:18 AM
Apax close to $500 mln deal to buy Israels Syneron - reportsApax close to $500 mln deal to buy Israel's Syneron - reports
uk.finance.yahoo.com - April 2 at 8:31 AM
Form 6-K Syneron Medical Ltd. For: Mar 27 - StreetInsider.comForm 6-K Syneron Medical Ltd. For: Mar 27 - StreetInsider.com
www.streetinsider.com - March 28 at 9:40 PM
Syneron Medical: Still Frustrating - And Still Tantalizing - Seeking AlphaSyneron Medical: Still Frustrating - And Still Tantalizing - Seeking Alpha
seekingalpha.com - February 24 at 5:43 PM
Syneron Medical 4Q Loss 3 Cents a Share (ELOS)Syneron Medical 4Q Loss 3 Cents a Share (ELOS)
www.investopedia.com - February 16 at 4:40 PM
Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 MillionSyneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 Million
us.rd.yahoo.com - February 16 at 4:40 PM
7:02 am Syneron Medical beats by $0.05, beats on revs7:02 am Syneron Medical beats by $0.05, beats on revs
us.rd.yahoo.com - February 16 at 4:40 PM
Q4 2016 Syneron Medical Ltd Earnings Release - Before Market OpenQ4 2016 Syneron Medical Ltd Earnings Release - Before Market Open
us.rd.yahoo.com - February 16 at 4:40 PM
Syneron Medical Reports 4Q Loss of 3 Cents a ShareSyneron Medical Reports 4Q Loss of 3 Cents a Share
www.investopedia.com - February 16 at 4:40 PM
UPDATE 2-Hologic buys Cynosure to expand into medical aesthetics - NasdaqUPDATE 2-Hologic buys Cynosure to expand into medical aesthetics - Nasdaq
www.nasdaq.com - February 14 at 5:51 PM
Sientra (SIEN) Names Philippe Schaison to Board of DirectorsSientra (SIEN) Names Philippe Schaison to Board of Directors
www.streetinsider.com - February 7 at 6:06 PM
Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources - PR Newswire (press release)Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources - PR Newswire (press release)
www.prnewswire.com - January 31 at 5:37 PM

SEC Filings

Syneron Medical (NASDAQ:ELOS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Syneron Medical (NASDAQ:ELOS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Syneron Medical (NASDAQ ELOS) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.